Cargando…

Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors

BACKGROUND & AIMS: After HCV cure, not all patients achieve significant liver fibrosis regression. We explored the effects of clinical and socio-behavioral factors on liver fibrosis, before and after HCV cure with direct-acting antivirals. METHODS: We analyzed data from the ongoing ANRS CO22 HEP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrieri, Patrizia, Carrat, Fabrice, Di Beo, Vincent, Bourlière, Marc, Barré, Tangui, De Ledinghen, Victor, Pageaux, Georges-Philippe, Bureau, Morgane, Cagnot, Carole, Dorival, Céline, Delarocque-Astagneau, Elisabeth, Marcellin, Fabienne, Pol, Stanislas, Fontaine, Hélène, Protopopescu, Camelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065909/ https://www.ncbi.nlm.nih.gov/pubmed/35514789 http://dx.doi.org/10.1016/j.jhepr.2022.100481

Ejemplares similares

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
por: Barré, Tangui, et al.
Publicado: (2022)

Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort)
por: Barré, Tangui, et al.
Publicado: (2022)

Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)
por: Barré, Tangui, et al.
Publicado: (2022)

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)
por: Barré, Tangui, et al.
Publicado: (2019)

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)
por: Marcellin, Fabienne, et al.
Publicado: (2022)

Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study)
por: Rolland, Benjamin, et al.
Publicado: (2022)

Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)
por: Antwerpes, Saskia, et al.
Publicado: (2020)

Mindfulness as a Protective Factor Against Increased Tobacco and Alcohol Use in Hospital Workers Following the First COVID-19-Related Lockdown: a Study in Southern France
por: Barré, Tangui, et al.
Publicado: (2022)

Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine
por: Fortin, Davide, et al.
Publicado: (2022)

Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock?
por: Barré, Tangui, et al.
Publicado: (2023)

Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015
por: Brouard, Cécile, et al.
Publicado: (2017)

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)
por: Barré, Tangui, et al.
Publicado: (2022)

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
por: Pageaux, Georges-Philippe, et al.
Publicado: (2022)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
por: Fortin, Davide, et al.
Publicado: (2021)

A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use
por: Fortin, Davide, et al.
Publicado: (2022)

External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
por: Poynard, Thierry, et al.
Publicado: (2021)

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study
por: About, Frédégonde, et al.
Publicado: (2015)

Gaining Greater Insight into HCV Emergence in HIV-Infected Men Who Have Sex with Men: The HEPAIG Study
por: Larsen, Christine, et al.
Publicado: (2011)

A Community-Based Therapeutic Education Programme for People with Alcohol Use Disorder in France: A Qualitative Study (ETHER)
por: Costa, Marie, et al.
Publicado: (2022)

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort
por: Laurain, Anne, et al.
Publicado: (2019)

Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS CO-13 HEPAVIH Cohort)
por: Yaya, Issifou, et al.
Publicado: (2018)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER)
por: Antwerpes, Saskia, et al.
Publicado: (2022)

New anti HCV drugs in the pipeline
por: Bourlière, Marc
Publicado: (2010)

Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes
por: Carrieri, Patrizia, et al.
Publicado: (2022)

Social and professional recognition are key determinants of quality of life at work among night-shift healthcare workers in Paris public hospitals (AP-HP ALADDIN COVID-19 survey)
por: Duracinsky, Martin, et al.
Publicado: (2022)

Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions
por: Roux, Perrine, et al.
Publicado: (2014)

Cannabidiol use and perceptions in France: a national survey
por: Casanova, Clémence, et al.
Publicado: (2022)

Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial)
por: Marcellin, Fabienne, et al.
Publicado: (2022)

Access to care for people with alcohol use disorder in France: a mixed-method cross-sectional study protocol (ASIA)
por: Costa, Marie, et al.
Publicado: (2018)

Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014
por: Sanna, Alice, et al.
Publicado: (2017)

Use of psychoactive substances by night-shift hospital healthcare workers during the first wave of the COVID-19 pandemic: a cross-sectional study based in Parisian public hospitals (ALADDIN)
por: Cousin, Lorraine, et al.
Publicado: (2022)

Negative representations of night-shift work and mental health of public hospital healthcare workers in the COVID-19 era (Aladdin survey)
por: Cousin Cabrolier, Lorraine, et al.
Publicado: (2023)

Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study
por: Anwar, Ilhame, et al.
Publicado: (2023)

Gestion de la COVID-19 : perceptions et expériences des personnels de nuit lors de la première vague de la pandémie dans les hôpitaux publics parisiens (enquête AP–HP ALADDIN)
por: Duracinsky, M., et al.
Publicado: (2021)

Correction: Non‑disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community‑based research study
por: Anwar, Ilhame, et al.
Publicado: (2023)

French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long
por: Brouard, Cécile, et al.
Publicado: (2020)

HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy
por: Brouard, Cécile, et al.
Publicado: (2019)

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
por: Nahon, Pierre, et al.
Publicado: (2021)

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
por: Mangia, Alessandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ad515da03akgpkhuc1dji09g3e